Diabetes lures pharma to the Gulf

Share this article:

Diabetes is a growing problem and pharmaceutical opportunity in Saudi Arabia. The Wall Street Journal outlines the health crisis that is increasingly visible during mall walks that double as a respite from the heat and a time to mingle over fast food.

The Journal also notes that governments in the Gulf have offered a mix of financial incentives to coax businesses to take manufacturing local, and that companies like Merck KGaA have partnered with local producers as a way of getting a foothold in the market.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.